Avicanna Files a Patent to Protect its Advanced Oral Cannabinoid Platform and its Applications for Neurological Diseases
06 déc. 2021 07h30 HE
|
Avicanna Inc.
Proprietary formulations include a range of liquids, capsules, powders, and controlled release tablets utilizing Avicanna’s self-emulsifying drug delivery systems (SEDDS) technology The advanced...
Avicanna Enters into an Intellectual Property Licensing and Distribution Agreement with Established Pharmaceutical Company in Argentina
30 nov. 2021 07h30 HE
|
Avicanna Inc.
TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region with Initial Export to Barbados
25 nov. 2021 07h30 HE
|
Avicanna Inc.
Starting with 3 SKUs, the advanced medical cannabis formulary will be available for the medical community and patients through prescriptionDistribution partnership with Bryden Stokes Limited includes...
Avicanna Announces Filing of Interim Financial Statements for the Three-Month Period Ending September 30, 2021, Demonstrating Progressive Commercialization Results
12 nov. 2021 07h30 HE
|
Avicanna Inc.
Record gross revenue of $1,007,033 through steady growth and progression of global commercializationDelivered a record number (27,041) of units of cannabis 2.0 products globally, an increase of 61%...
Avicanna Announces Resignation of Director
11 nov. 2021 19h30 HE
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Viola Brands Launches Nationwide in Canada through the Medical Cannabis by Shoppers™ online platform
09 nov. 2021 07h30 HE
|
Avicanna Inc.
Avicanna’s partnership with Viola brings the equity-focused brand founded by NBA veteran, Al Harrington, to Canada for the first time. Initial products will be available nationwide on the medical...
Avicanna Inc. to Host Third Quarter 2021 Investor Conference Call on November 12 and Announces Warrant Repricing
08 nov. 2021 07h30 HE
|
Avicanna Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Announces Management Change
05 nov. 2021 19h19 HE
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna´s subsidiary obtains Good Agricultural and Collection Practices (“GACP”) Certification in Colombia
04 nov. 2021 07h30 HE
|
Avicanna Inc.
The certification will allow the Company’s Aureus-branded raw material business with sales in 11 countries to include low cost and sustainable cannabis biomass for sale and export to the global...
Avicanna Completes Commercial Export of CBD Isolate and CBD Full Spectrum Psychoactive Derivatives from Colombia to Chile
22 oct. 2021 07h30 HE
|
Avicanna Inc.
The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own...